Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Sandu Pharmaceuticals Ltd

NSE: SANDUPHQ · BSE: 524703 · Pharmaceuticals & Biotechnology · 21 announcements

Share price
₹36.82
Market cap
₹35.57 Cr
Revenue (annual)
₹69.93 Cr
Net profit (annual)
₹1.77 Cr
P/E (TTM)
14.6×Sector 47.4×
Promoter holding
37.79%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:26 IST BSE
Management Change

Sandu Pharmaceuticals Management Change

Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.

17:28 IST BSE
Management Change

Sandu Pharmaceuticals Management Change

Sandu Pharmaceuticals announced the demise of MD Shri Umesh B. Sandu. Consequently, Shri Balram Viswanathan was redesignated as Chairman and MD, and Dr. Neeti Kapre was appointed Independent Director.